| C552819 | 10-(octyloxy)decyl-2-(trimethylammonium)ethyl phosphate | 10-(octyloxy)decyl-2-(trimethylammonium)ethyl phosphate inhibits the reaction [[IL3 protein co-treated with CSF2 protein co-treated with FLT3LG protein co-treated with KITLG protein] results in increased expression of LAT2 protein] | 23001822 |
| C552819 | 10-(octyloxy)decyl-2-(trimethylammonium)ethyl phosphate | 10-(octyloxy)decyl-2-(trimethylammonium)ethyl phosphate inhibits the reaction [[IL3 protein co-treated with CSF2 protein co-treated with FLT3LG protein co-treated with KITLG protein] results in increased phosphorylation of AKT1 protein] | 23001822 |
| C552819 | 10-(octyloxy)decyl-2-(trimethylammonium)ethyl phosphate | 10-(octyloxy)decyl-2-(trimethylammonium)ethyl phosphate inhibits the reaction [[IL3 protein co-treated with CSF2 protein co-treated with FLT3LG protein co-treated with KITLG protein] results in increased phosphorylation of RPS6 protein] | 23001822 |
| C070379 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester | "1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [kaempferol results in increased secretion of CSF2 protein]" | 18346843 |
| C070379 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester | "1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Quercetin results in increased secretion of CSF2 protein]" | 18346843 |
| C038983 | 1,3-dimethylthiourea | "1,3-dimethylthiourea inhibits the reaction [Particulate Matter results in increased secretion of CSF2 protein]" | 10645887 |
| C038983 | 1,3-dimethylthiourea | "1,3-dimethylthiourea inhibits the reaction [Vehicle Emissions results in increased secretion of CSF2 protein]" | 10645887 |
| C038983 | 1,3-dimethylthiourea | "1,3-dimethylthiourea inhibits the reaction [IL1B protein results in increased expression of CSF2 protein]" | 11752025 |
| C038983 | 1,3-dimethylthiourea | "1,3-dimethylthiourea inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 protein]" | 11752025 |
| C038983 | 1,3-dimethylthiourea | "1,3-dimethylthiourea inhibits the reaction [Reactive Oxygen Species results in increased expression of CSF2 protein]" | 11752025 |
| C038983 | 1,3-dimethylthiourea | "1,3-dimethylthiourea inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CSF2 protein]" | 11752025 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | "15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IL1B protein results in increased expression of CSF2 mRNA]" | 14998300 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | "15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IL1B protein results in increased expression of CSF2 protein]" | 14998300 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | "15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 mRNA]" | 12604364 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | "Dexamethasone promotes the reaction [15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IL1B protein results in increased expression of CSF2 mRNA]]" | 14998300 |
| C060229 | 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione | "1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [kaempferol results in increased secretion of CSF2 protein]" | 18346843 |
| C060229 | 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione | "1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [Quercetin results in increased secretion of CSF2 protein]" | 18346843 |
| C032668 | 1-nitropyrene | 1-nitropyrene results in increased expression of CSF2 mRNA | 21540303 |
| C532162 | 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | "2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine results in decreased susceptibility to CSF2 protein" | 22315502 |
| C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether inhibits the reaction [Lipopolysaccharides results in increased secretion of CSF2 protein]" | 19211157 |
| C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Particulate Matter results in increased secretion of CSF2 protein] | 10645887|1946041 |
| C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Vehicle Emissions results in increased secretion of CSF2 protein] | 10645887 |
| C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased secretion of CSF2 protein | 10645887 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [PTPN11 protein mutant form results in increased susceptibility to CSF2 protein] | 22315502 |
| C469683 | 2-(6-((3-(4-(diphenylmethoxy)piperidino)propyl)amino)imidazo(1,2-b)pyridazin-2-yl)-2-methylpropionic acid | "2-(6-((3-(4-(diphenylmethoxy)piperidino)propyl)amino)imidazo(1,2-b)pyridazin-2-yl)-2-methylpropionic acid inhibits the reaction [Dexamethasone results in increased expression of CSF2 mRNA]" | 12438553 |
| C012796 | 2-butenal | 2-butenal results in decreased expression of CSF2 mRNA | 20471460 |
| C012796 | 2-butenal | 2-butenal results in decreased secretion of CSF2 protein | 17491020 |
| C035419 | 3,4-dihydroxybenzohydroxamic acid | "3,4-dihydroxybenzohydroxamic acid inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 mRNA]" | 25843059 |
| C035419 | 3,4-dihydroxybenzohydroxamic acid | "3,4-dihydroxybenzohydroxamic acid results in decreased expression of CSF2 mRNA" | 25843059 |
| C434003 | 3-(4-methylphenylsulfonyl)-2-propenenitrile | [3-(4-methylphenylsulfonyl)-2-propenenitrile co-treated with CSF2] results in decreased activity of RELA protein | 16174796 |
| C106592 | 3,9-bis((ethylthio)methyl)-K-252a | "3,9-bis((ethylthio)methyl)-K-252a results in decreased expression of CSF2 mRNA" | 15294995 |
| C027576 | 4-hydroxy-2-nonenal | 4-hydroxy-2-nonenal results in decreased expression of CSF2 mRNA | 19191707 |
| C041594 | 4-nonylphenol | 4-nonylphenol results in increased secretion of CSF2 protein | 20194071 |
| C029728 | 4-phenylenediamine | 4-phenylenediamine results in increased secretion of CSF2 protein | 22245253 |
| C080828 | 5-oxo-6,8,11,14-eicosatetraenoic acid | "5-oxo-6,8,11,14-eicosatetraenoic acid results in increased secretion of CSF2 protein" | 15136573 |
| C003001 | 7-ketocholesterol | 7-ketocholesterol results in increased expression of CSF2 protein | 24895526 |
| C003001 | 7-ketocholesterol | resveratrol inhibits the reaction [7-ketocholesterol results in increased expression of CSF2 protein] | 24895526 |
| D000079 | Acetaldehyde | Acetaldehyde results in increased secretion of CSF2 protein | 14619338 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of CSF2 mRNA | 20363829 |
| C056165 | acetovanillone | acetovanillone inhibits the reaction [TNF protein results in increased expression of CSF2 mRNA] | 22414048 |
| D000109 | Acetylcholine | Acetylcholine results in increased secretion of CSF2 protein | 9606035 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of and results in increased secretion of CSF2 protein] | 26138014 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Particulate Matter analog results in increased secretion of CSF2 protein] | 10645887 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of CSF2 protein] | 10645887|1946041 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Vehicle Emissions analog results in increased secretion of CSF2 protein] | 10645887 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased secretion of CSF2 protein] | 10645887 |
| D000171 | Acrolein | Acrolein results in decreased secretion of CSF2 protein | 17491020 |
| D020106 | Acrylamide | Acrylamide results in decreased expression of CSF2 mRNA | 28959563 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased expression of CSF2 mRNA | 22100608 |
| C430898 | AGN 194204 | AGN 194204 results in decreased expression of CSF2 mRNA | 16339527 |
| D000393 | Air Pollutants | Air Pollutants results in increased expression of CSF2 mRNA | 19482827 |
| D000393 | Air Pollutants | Air Pollutants results in increased expression of CSF2 protein | 19482827 |
| D000393 | Air Pollutants | Air Pollutants results in increased secretion of CSF2 protein | 23159501 |
| D000393 | Air Pollutants | Atorvastatin Calcium inhibits the reaction [Air Pollutants results in increased expression of CSF2 mRNA] | 19482827 |
| D000393 | Air Pollutants | Atorvastatin Calcium inhibits the reaction [Air Pollutants results in increased expression of CSF2 protein] | 19482827 |
| D000420 | Albuterol | [Beclomethasone co-treated with Albuterol] results in decreased secretion of CSF2 protein | 15679717 |
| C021137 | alclometasone dipropionate | alclometasone dipropionate results in decreased expression of CSF2 protein | 11407316 |
| D013196 | Dihydrotestosterone | Dihydrotestosterone inhibits the reaction [TNF protein results in increased secretion of CSF2 protein] | 16317058 |
| C011512 | alpha-naphthoflavone | alpha-naphthoflavone inhibits the reaction [Particulate Matter results in increased expression of CSF2 mRNA] | 20801209 |
| D000534 | Alum Compounds | Alum Compounds inhibits the reaction [[CSF2 protein co-treated with IL4 protein] results in increased expression of CD1A protein] | 18390722 |
| D000534 | Alum Compounds | Alum Compounds inhibits the reaction [[CSF2 protein co-treated with IL4 protein] results in increased expression of CD80 protein] | 18390722 |
| D000534 | Alum Compounds | Alum Compounds promotes the reaction [[CSF2 protein co-treated with IL4 protein] results in increased expression of CCR7 protein] | 18390722 |
| D000534 | Alum Compounds | Alum Compounds promotes the reaction [[CSF2 protein co-treated with IL4 protein] results in increased expression of TFRC protein] | 18390722 |
| D000534 | Alum Compounds | Alum Compounds promotes the reaction [CSF2 protein results in increased expression of CD86 protein] | 18390722 |
| D000536 | Aluminum Hydroxide | Aluminum Hydroxide inhibits the reaction [[CSF2 protein co-treated with IL4 protein] results in increased expression of CD1A protein] | 18390722 |
| D000536 | Aluminum Hydroxide | Aluminum Hydroxide inhibits the reaction [[CSF2 protein co-treated with IL4 protein] results in increased expression of CD80 protein] | 18390722 |
| D000536 | Aluminum Hydroxide | Aluminum Hydroxide promotes the reaction [[CSF2 protein co-treated with IL4 protein] results in increased expression of CCR7 protein] | 18390722 |
| D000536 | Aluminum Hydroxide | Aluminum Hydroxide promotes the reaction [[CSF2 protein co-treated with IL4 protein] results in increased expression of TFRC protein] | 18390722 |
| D000536 | Aluminum Hydroxide | Aluminum Hydroxide promotes the reaction [CSF2 protein results in increased expression of CD86 protein] | 18390722 |
| D000537 | Aluminum Oxide | Aluminum Oxide results in increased secretion of CSF2 protein | 15046894 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of CSF2 mRNA | 16483693 |
| C054105 | ammonium trichloro(dioxoethylene-O,O'-)tellurate | "ammonium trichloro(dioxoethylene-O,O'-)tellurate results in increased secretion of CSF2 protein" | 7498364 |
| C100395 | andrastin A | andrastin A results in increased expression of and results in increased secretion of CSF2 protein | 28535995 |
| D039741 | Antigens, Dermatophagoides | "Antigens, Dermatophagoides results in increased expression of CSF2 mRNA" | 11167953 |
| D039741 | Antigens, Dermatophagoides | "Antigens, Dermatophagoides results in increased secretion of CSF2 protein" | 11167953|1207727 |
| D039741 | Antigens, Dermatophagoides | "Beclomethasone inhibits the reaction [Antigens, Dermatophagoides results in increased expression of CSF2 mRNA]" | 11167953 |
| D039741 | Antigens, Dermatophagoides | "Beclomethasone inhibits the reaction [Antigens, Dermatophagoides results in increased secretion of CSF2 protein]" | 11167953 |
| D039741 | Antigens, Dermatophagoides | "Salmeterol Xinafoate inhibits the reaction [Antigens, Dermatophagoides results in increased secretion of CSF2 protein]" | 9344832 |
| D001152 | Arsenicals | Arsenicals results in increased expression of CSF2 protein | 11312651 |
| C006632 | arsenic trioxide | [arsenic trioxide co-treated with CSF2] results in decreased activity of RELA protein | 16174796 |
| C006632 | arsenic trioxide | [CSF2 protein co-treated with arsenic trioxide] affects the activity of CASP3 protein | 16174796 |
| C006632 | arsenic trioxide | [CSF2 protein co-treated with arsenic trioxide] results in decreased expression of and affects the activity of CASP8 protein | 16174796 |
| C006632 | arsenic trioxide | [CSF2 protein co-treated with arsenic trioxide] results in decreased expression of and results in increased cleavage of CASP3 protein | 16174796 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of CSF2 mRNA | 29049341 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of CSF2 protein | 29049341 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of CSF2 mRNA | 22465848 |
| D001194 | Asbestos | Asbestos results in increased expression of CSF2 mRNA | 22398240 |
| D017636 | Asbestos, Amphibole | "Asbestos, Amphibole results in increased expression of CSF2 protein" | 20855422 |
| D017636 | Asbestos, Amphibole | "[Asbestos, Amphibole results in increased secretion of IL1B protein] which results in increased secretion of CSF2 protein" | 23017228 |
| D017638 | Asbestos, Crocidolite | "Asbestos, Crocidolite results in increased expression of CSF2 mRNA" | 11250057|2416032 |
| D017638 | Asbestos, Crocidolite | "Asbestos, Crocidolite results in increased expression of CSF2 protein" | 11250057 |
| D000069059 | Atorvastatin Calcium | Atorvastatin Calcium inhibits the reaction [Air Pollutants results in increased expression of CSF2 mRNA] | 19482827 |
| D000069059 | Atorvastatin Calcium | Atorvastatin Calcium inhibits the reaction [Air Pollutants results in increased expression of CSF2 protein] | 19482827 |
| D000069059 | Atorvastatin Calcium | Atorvastatin Calcium inhibits the reaction [Particulate Matter results in increased expression of CSF2 mRNA] | 19482827 |
| D000069059 | Atorvastatin Calcium | Atorvastatin Calcium inhibits the reaction [Particulate Matter results in increased expression of CSF2 protein] | 19482827 |
| C006680 | baicalein | baicalein results in decreased expression of CSF2 mRNA | 10718847 |
| D001507 | Beclomethasone | [Beclomethasone co-treated with Albuterol] results in decreased secretion of CSF2 protein | 15679717 |
| D001507 | Beclomethasone | [Beclomethasone co-treated with Formoterol Fumarate] results in decreased secretion of CSF2 protein | 15679717 |
| D001507 | Beclomethasone | "Beclomethasone inhibits the reaction [Antigens, Dermatophagoides results in increased expression of CSF2 mRNA]" | 11167953 |
| D001507 | Beclomethasone | "Beclomethasone inhibits the reaction [Antigens, Dermatophagoides results in increased secretion of CSF2 protein]" | 11167953 |
| D001507 | Beclomethasone | Beclomethasone inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein] | 10460758 |
| D001507 | Beclomethasone | Beclomethasone results in decreased secretion of CSF2 protein | 10868704|7545059 |
| D001507 | Beclomethasone | Beclomethasone results in increased activity of CSF2 protein | 11730731 |
| D001554 | Benzene | Benzene results in increased expression of CSF2 protein | 11306435 |
| D001554 | Benzene | [Benzene co-treated with Enzyme Inhibitors] promotes the reaction [[Lipopolysaccharides co-treated with CSF2 protein] results in increased chemical synthesis of Nitric Oxide] | 8193360 |
| D001554 | Benzene | Benzene promotes the reaction [[CSF2 protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide] | 7884313 |
| D001554 | Benzene | Benzene promotes the reaction [[Lipopolysaccharides co-treated with CSF2 protein] results in increased chemical synthesis of Nitric Oxide] | 8193360 |
| D001554 | Benzene | Benzene promotes the reaction [[[Lipopolysaccharides co-treated with IFNG protein] co-treated with CSF2 protein] results in increased chemical synthesis of Nitric Oxide] | 8193360 |
| D001554 | Benzene | Benzene results in decreased secretion of CSF2 protein | 27339418 |
| D001554 | Benzene | Benzene results in increased susceptibility to CSF2 protein | 8193360 |
| D001554 | Benzene | [Formaldehyde co-treated with Benzene] results in decreased secretion of CSF2 protein | 27339418 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of CSF2 protein | 11306435 |
| D001624 | Betamethasone Valerate | Betamethasone Valerate results in decreased expression of CSF2 protein | 11407316 |
| D001663 | Bilirubin | Bilirubin results in increased expression of CSF2 mRNA | 20196124 |
| C070515 | bisindolylmaleimide I | bisindolylmaleimide I inhibits the reaction [kaempferol results in increased secretion of CSF2 protein] | 18346843 |
| C070515 | bisindolylmaleimide I | bisindolylmaleimide I inhibits the reaction [Quercetin results in increased secretion of CSF2 protein] | 18346843 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of CSF2 mRNA | 18007998 |
| C006780 | bisphenol A | bisphenol A affects the expression of CSF2 mRNA | 25181051 |
| D001761 | Bleomycin | Bleomycin results in increased expression of CSF2 protein | 18684396 |
| C032688 | boric acid | boric acid results in increased expression of CSF2 protein | 27206737 |
| D020126 | Brefeldin A | Brefeldin A inhibits the reaction [kaempferol results in increased secretion of CSF2 protein] | 18346843 |
| D020126 | Brefeldin A | Brefeldin A inhibits the reaction [Quercetin results in increased secretion of CSF2 protein] | 18346843 |
| C016274 | bromoacetate | bromoacetate results in increased expression of CSF2 mRNA | 19753638 |
| D019819 | Budesonide | Budesonide inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein] | 10460758 |
| D019819 | Budesonide | Budesonide results in decreased secretion of CSF2 protein | 10868704|7621058 |
| D019819 | Budesonide | Budesonide results in increased activity of CSF2 protein | 11730731 |
| D002084 | Butylated Hydroxytoluene | Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of CSF2 protein] | 16822543 |
| D002104 | Cadmium | Cadmium results in increased expression of and results in increased secretion of CSF2 protein | 18082304 |
| D002104 | Cadmium | Cadmium affects the expression of CSF2 protein | 20826145 |
| D019256 | Cadmium Chloride | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of and results in increased secretion of CSF2 protein] | 26138014 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of and results in increased secretion of CSF2 protein | 26138014 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of CSF2 mRNA | 20061341 |
| D000001 | Calcimycin | Cyclosporine inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CSF2 protein] | 1376361 |
| D000001 | Calcimycin | Sirolimus inhibits the reaction [Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CSF2 protein]] | 1376361 |
| D000001 | Calcimycin | Tacrolimus inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CSF2 protein] | 1376361 |
| D000001 | Calcimycin | [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CSF2 protein | 1376361 |
| D000001 | Calcimycin | Calcimycin results in increased expression of CSF2 mRNA | 17950587 |
| D000001 | Calcimycin | Luteolin inhibits the reaction [Calcimycin results in increased expression of CSF2 mRNA] | 17950587 |
| D000001 | Calcimycin | thunberginol B inhibits the reaction [Calcimycin results in increased expression of CSF2 mRNA] | 17950587 |
| D002211 | Capsaicin | Capsaicin results in increased expression of CSF2 protein | 22150557 |
| D002211 | Capsaicin | [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CSF2 protein] | 22150557 |
| D002211 | Capsaicin | Naproxen inhibits the reaction [Capsaicin results in increased expression of CSF2 protein] | 22150557 |
| D002211 | Capsaicin | Sumatriptan inhibits the reaction [Capsaicin results in increased expression of CSF2 protein] | 22150557 |
| D002330 | Carmustine | CSF2 mRNA affects the susceptibility to Carmustine | 16365179 |
| C043211 | carvedilol | carvedilol inhibits the reaction [CSF2 results in increased expression of IL10 mRNA] | 12722941 |
| C043211 | carvedilol | carvedilol inhibits the reaction [CSF2 results in increased expression of IL10 protein] | 12722941 |
| C469298 | CEP-11004 | CEP-11004 results in decreased expression of CSF2 mRNA | 15294995 |
| D002635 | Chenodeoxycholic Acid | Chenodeoxycholic Acid results in increased expression of CSF2 mRNA | 21224055 |
| D002635 | Chenodeoxycholic Acid | EGR1 promotes the reaction [Chenodeoxycholic Acid results in increased expression of CSF2 mRNA] | 21224055 |
| D002713 | Chlorine | Chlorine results in increased expression of CSF2 protein | 23146759 |
| D002939 | Ciprofloxacin | Ciprofloxacin results in increased expression of CSF2 protein | 11125792 |
| D002990 | Clobetasol | Clobetasol results in decreased secretion of CSF2 protein | 15086553 |
| C000593591 | coagulin-L | coagulin-L inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 protein] | 27568862 |
| C000593591 | coagulin-L | coagulin-L inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 protein] | 27568862 |
| D060729 | Coal Ash | Coal Ash results in increased expression of CSF2 protein | 18684396 |
| D003035 | Cobalt | Cobalt results in increased expression of CSF2 mRNA | 22147119 |
| D003035 | Cobalt | [Organometallic Compounds co-treated with Cobalt] results in increased expression of CSF2 mRNA | 22147119 |
| D003035 | Cobalt | [Nickel co-treated with Cobalt co-treated with Tungsten] results in increased expression of CSF2 mRNA | 22198552 |
| D009243 | NAD | [NAD results in increased abundance of Reactive Oxygen Species] which results in increased expression of CSF2 protein | 11752025 |
| D003078 | Colchicine | Colchicine inhibits the reaction [kaempferol results in increased secretion of CSF2 protein] | 18346843 |
| D003078 | Colchicine | Colchicine inhibits the reaction [Quercetin results in increased secretion of CSF2 protein] | 18346843 |
| C055786 | columbamine | columbamine inhibits the reaction [CSF2 protein results in increased phosphorylation of STAT3 protein] | 23124089 |
| D003436 | Croton Oil | Croton Oil results in increased expression of CSF2 protein | 8006454 |
| D003436 | Croton Oil | "lipopolysaccharide, E coli O55-B5 inhibits the reaction [Croton Oil results in increased expression of CSF2 protein]" | 8006454 |
| D003436 | Croton Oil | Croton Oil results in increased expression of CSF2 mRNA | 18652873 |
| C038459 | curdlan | curdlan results in increased expression of CSF2 mRNA | 23543010 |
| C057862 | cyanoginosin LR | cyanoginosin LR inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 mRNA] | 15712326 |
| C057862 | cyanoginosin LR | cyanoginosin LR results in decreased expression of CSF2 mRNA | 23454832 |
| C057862 | cyanoginosin LR | cyanoginosin LR results in decreased expression of CSF2 protein | 23454832 |
| D003513 | Cycloheximide | Cycloheximide inhibits the reaction [IL1B results in increased secretion of CSF2 protein] | 9606035 |
| D003513 | Cycloheximide | Cycloheximide inhibits the reaction [Particulate Matter results in increased secretion of CSF2 protein] | 10645887 |
| D003513 | Cycloheximide | Cycloheximide inhibits the reaction [Vehicle Emissions results in increased secretion of CSF2 protein] | 10645887 |
| D003520 | Cyclophosphamide | CSF2 protein affects the activity of Cyclophosphamide | 8349185 |
| D003520 | Cyclophosphamide | Cyclophosphamide results in increased expression of CSF2 protein | 18848347 |
| D016572 | Cyclosporine | Cyclosporine inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CSF2 protein] | 1376361 |
| D016572 | Cyclosporine | Cyclosporine results in increased expression of CSF2 mRNA | 23958496 |
| D003571 | Cytochalasin B | Cytochalasin B inhibits the reaction [kaempferol results in increased secretion of CSF2 protein] | 18346843 |
| D003571 | Cytochalasin B | Cytochalasin B inhibits the reaction [Quercetin results in increased secretion of CSF2 protein] | 18346843 |
| D015638 | Cytochalasin D | Cytochalasin D inhibits the reaction [Particulate Matter results in increased secretion of CSF2 protein] | 10645887 |
| D015638 | Cytochalasin D | Cytochalasin D inhibits the reaction [Vehicle Emissions results in increased secretion of CSF2 protein] | 10645887 |
| D003609 | Dactinomycin | Dactinomycin inhibits the reaction [IL1B results in increased secretion of CSF2 protein] | 9606035 |
| D003609 | Dactinomycin | Dactinomycin inhibits the reaction [Particulate Matter results in increased secretion of CSF2 protein] | 10645887 |
| D003609 | Dactinomycin | Dactinomycin inhibits the reaction [Vehicle Emissions results in increased secretion of CSF2 protein] | 10645887 |
| D003609 | Dactinomycin | Dactinomycin inhibits the reaction [Reactive Oxygen Species results in increased expression of CSF2 protein] | 11752025 |
| D000069439 | Dasatinib | Dasatinib results in decreased expression of CSF2 protein | 17962511 |
| D003671 | DEET | [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of CSF2 mRNA | 28659758 |
| D003676 | Deferoxamine | Deferoxamine inhibits the reaction [Particulate Matter results in increased expression of CSF2 mRNA] | 20801209|2170334 |
| D003840 | Deoxycholic Acid | Deoxycholic Acid results in increased expression of CSF2 mRNA | 21224055 |
| D003840 | Deoxycholic Acid | EGR1 promotes the reaction [Deoxycholic Acid results in increased expression of CSF2 mRNA] | 21224055 |
| D003907 | Dexamethasone | "2-(6-((3-(4-(diphenylmethoxy)piperidino)propyl)amino)imidazo(1,2-b)pyridazin-2-yl)-2-methylpropionic acid inhibits the reaction [Dexamethasone results in increased expression of CSF2 mRNA]" | 12438553 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [IL13 protein results in increased secretion of CSF2 protein] | 12077271 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein] | 12070353 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [IL4 protein results in increased secretion of CSF2 protein] | 12077271 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 protein] | 27568862 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [lipoteichoic acid results in increased secretion of CSF2 protein] | 23981542 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [TNF protein results in increased expression of CSF2 mRNA] | 19255438 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [TNF protein results in increased secretion of CSF2 protein] | 20801891 |
| D003907 | Dexamethasone | "Dexamethasone inhibits the reaction [[Toluene 2,4-Diisocyanate binds to ALB protein] which results in increased expression of CSF2 protein]" | 16908450 |
| D003907 | Dexamethasone | "Dexamethasone promotes the reaction [15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IL1B protein results in increased expression of CSF2 mRNA]]" | 14998300 |
| D003907 | Dexamethasone | Dexamethasone results in decreased expression of CSF2 mRNA | 10596698 |
| D003907 | Dexamethasone | Dexamethasone results in increased activity of CSF2 protein | 11730731 |
| D003907 | Dexamethasone | [Theophylline co-treated with Dexamethasone] inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein] | 12070353 |
| D003907 | Dexamethasone | [trichostatin A co-treated with Dexamethasone] inhibits the reaction [IL1B protein promotes the reaction [HIST4H4 protein modified form binds to CSF2 promoter]] | 12070353 |
| D003907 | Dexamethasone | trichostatin A inhibits the reaction [Dexamethasone inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein]] | 12070353 |
| D003907 | Dexamethasone | trichostatin A inhibits the reaction [[Theophylline co-treated with Dexamethasone] inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein]] | 12070353 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 mRNA] | 16880258 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 protein] | 27568862 |
| D016264 | Dextran Sulfate | Dextran Sulfate results in increased expression of CSF2 mRNA | 15652231 |
| D016264 | Dextran Sulfate | Rutin inhibits the reaction [Dextran Sulfate results in increased expression of CSF2 mRNA] | 15652231 |
| D002945 | Cisplatin | [Cisplatin co-treated with TNF protein] results in increased expression of CSF2 mRNA | 23103562 |
| D002945 | Cisplatin | Cisplatin results in increased expression of CSF2 mRNA | 26546572 |
| D002945 | Cisplatin | Cisplatin results in increased expression of CSF2 protein | 20844023 |
| D004051 | Diethylhexyl Phthalate | [Diethylhexyl Phthalate co-treated with CSF2] results in increased expression of IFNG protein | 19428943 |
| D004051 | Diethylhexyl Phthalate | [Diethylhexyl Phthalate co-treated with CSF2] results in increased expression of IL10 protein | 19428943 |
| D004051 | Diethylhexyl Phthalate | [Diethylhexyl Phthalate co-treated with CSF2] results in increased expression of IL4 protein | 19428943 |
| D004052 | Diethylnitrosamine | [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of CSF2 mRNA | 18253720 |
| D000875 | Anthralin | Anthralin results in increased expression of CSF2 mRNA | 9628260 |
| D002117 | Calcitriol | Calcitriol results in decreased expression of CSF2 protein | 25458313 |
| D002117 | Calcitriol | Calcitriol results in decreased secretion of CSF2 protein | 25773153 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "9,10-Dimethyl-1,2-benzanthracene results in increased expression of CSF2 mRNA" | 14678569 |
| D004137 | Dinitrochlorobenzene | Dinitrochlorobenzene results in increased expression of CSF2 mRNA | 18652873 |
| D004137 | Dinitrochlorobenzene | Dinitrochlorobenzene results in increased secretion of CSF2 protein | 22245253 |
| C067311 | docetaxel | docetaxel results in increased secretion of CSF2 protein | 18346843 |
| D004365 | Drugs, Chinese Herbal | "Drugs, Chinese Herbal results in increased expression of and results in increased secretion of CSF2 protein" | 17963324 |
| D004365 | Drugs, Chinese Herbal | "Drugs, Chinese Herbal results in increased expression of CSF2 mRNA" | 17963324 |
| D004391 | Dust | Dust results in increased expression of CSF2 mRNA | 17805423|2105609 |
| D004391 | Dust | Dust results in increased expression of CSF2 protein | 17805423 |
| C509867 | E804 bisindole | E804 bisindole inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 mRNA] | 23107598 |
| C509867 | E804 bisindole | E804 bisindole results in increased expression of CSF2 mRNA | 23107598 |
| C509867 | E804 bisindole | Lipopolysaccharides inhibits the reaction [E804 bisindole results in increased expression of CSF2 mRNA] | 23107598 |
| D004533 | Egtazic Acid | Egtazic Acid inhibits the reaction [kaempferol results in increased secretion of CSF2 protein] | 18346843 |
| D004533 | Egtazic Acid | Egtazic Acid inhibits the reaction [Quercetin results in increased secretion of CSF2 protein] | 18346843 |
| D015118 | Eicosapentaenoic Acid | [procyanidin B3 co-treated with Eicosapentaenoic Acid] inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 mRNA] | 22169119 |
| D004791 | Enzyme Inhibitors | [Benzene co-treated with Enzyme Inhibitors] promotes the reaction [[Lipopolysaccharides co-treated with CSF2 protein] results in increased chemical synthesis of Nitric Oxide] | 8193360 |
| D004791 | Enzyme Inhibitors | Enzyme Inhibitors results in decreased susceptibility to CSF2 protein | 8193360 |
| D004791 | Enzyme Inhibitors | Enzyme Inhibitors results in increased susceptibility to [Lipopolysaccharides co-treated with CSF2 protein] | 8193360 |
| D000431 | Ethanol | Ethanol inhibits the reaction [Poly I-C results in increased expression of CSF2 protein] | 19500611 |
| D000431 | Ethanol | Ethanol results in decreased secretion of CSF2 protein | 20624996 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of CSF2 mRNA | 17942748 |
| D004997 | Ethinyl Estradiol | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CSF2 mRNA | 17942748 |
| C007650 | ethyl acetate | ethyl acetate results in increased expression of CSF2 protein | 11306435 |
| D015025 | Zearalenone | Zearalenone results in increased expression of CSF2 mRNA | 27757495 |
| D011345 | Fenofibrate | [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of CSF2 mRNA | 18253720 |
| C020748 | ferrous sulfate | ferrous sulfate results in increased expression of CSF2 mRNA | 21540303 |
| C109799 | FK 706 | FK 706 inhibits the reaction [IL1B protein results in increased expression of CSF2 protein] | 12676771 |
| C109799 | FK 706 | FK 706 inhibits the reaction [TNF protein results in increased expression of CSF2 protein] | 12676771 |
| D005419 | Flavonoids | Flavonoids results in decreased expression of CSF2 mRNA | 18035473 |
| D005472 | Fluorouracil | Fluorouracil results in increased expression of CSF2 mRNA | 18344199 |
| D000068298 | Fluticasone | Fluticasone inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein] | 10460758 |
| D000068298 | Fluticasone | Fluticasone results in decreased secretion of CSF2 protein | 10868704 |
| D000068298 | Fluticasone | Fluticasone results in increased activity of CSF2 protein | 11730731 |
| D005557 | Formaldehyde | Formaldehyde results in decreased expression of CSF2 mRNA | 28937961 |
| D005557 | Formaldehyde | Formaldehyde results in increased expression of and results in increased secretion of CSF2 protein | 18082304 |
| D005557 | Formaldehyde | [Formaldehyde co-treated with Benzene] results in decreased secretion of CSF2 protein | 27339418 |
| D005557 | Formaldehyde | Formaldehyde results in decreased expression of CSF2 protein | 28373009 |
| D000068759 | Formoterol Fumarate | [Beclomethasone co-treated with Formoterol Fumarate] results in decreased secretion of CSF2 protein | 15679717 |
| D005620 | Freund's Adjuvant | Freund's Adjuvant inhibits the reaction [Methylnitrosourea results in increased expression of CSF2 protein] | 16822543 |
| D005620 | Freund's Adjuvant | Freund's Adjuvant inhibits the reaction [Urethane results in decreased expression of CSF2 mRNA] | 12810352 |
| D005620 | Freund's Adjuvant | [Urethane co-treated with Freund's Adjuvant] results in increased expression of CSF2 mRNA | 12400877 |
| C056507 | gemcitabine | gemcitabine results in decreased expression of CSF2 protein | 20531411 |
| D019833 | Genistein | Genistein inhibits the reaction [Particulate Matter results in increased secretion of CSF2 protein] | 10645887 |
| D019833 | Genistein | Genistein inhibits the reaction [Vehicle Emissions results in increased secretion of CSF2 protein] | 10645887 |
| D005839 | Gentamicins | Gentamicins results in decreased expression of CSF2 protein | 25051504 |
| D005944 | Glucosamine | Glucosamine inhibits the reaction [IL1B results in increased expression of CSF2 mRNA] | 17109745 |
| D005944 | Glucosamine | Glucosamine results in increased expression of CSF2 mRNA | 17109745 |
| D006034 | Glycyrrhetinic Acid | Glycyrrhetinic Acid promotes the reaction [Hydrocortisone inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein]] | 10460758 |
| D006046 | Gold | [Gold co-treated with Silicon Dioxide] results in increased secretion of CSF2 protein | 22155353 |
| D006046 | Gold | Gold results in increased secretion of CSF2 protein | 22155353 |
| D006108 | Graphite | Graphite results in increased expression of CSF2 protein | 27440207 |
| C412815 | GW 4064 | GW 4064 results in increased expression of CSF2 mRNA | 26655953 |
| D006388 | Hemagglutinins | Hemagglutinins results in increased secretion of CSF2 protein | 22839698 |
| D006418 | Heme | Heme metabolite results in decreased expression of CSF2 mRNA | 19191707 |
| D007975 | Leukotriene B4 | Leukotriene B4 results in increased secretion of CSF2 protein | 15136573 |
| D006586 | Hexanes | Hexanes results in increased expression of CSF2 protein | 11306435 |
| D006632 | Histamine | Histamine results in increased expression of CSF2 protein | 9856766 |
| D006632 | Histamine | Histamine results in increased secretion of CSF2 protein | 10051702|9606035 |
| D006632 | Histamine | Particulate Matter analog promotes the reaction [Histamine results in increased secretion of CSF2 protein] | 10051702 |
| D006632 | Histamine | Vehicle Emissions analog promotes the reaction [Histamine results in increased secretion of CSF2 protein] | 10051702 |
| D006854 | Hydrocortisone | Glycyrrhetinic Acid promotes the reaction [Hydrocortisone inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein]] | 10460758 |
| D006854 | Hydrocortisone | Hydrocortisone inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein] | 10460758 |
| D006854 | Hydrocortisone | Hydrocortisone results in decreased secretion of CSF2 protein | 15086553 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased expression of CSF2 mRNA | 11378323 |
| C031927 | hydroquinone | [CSF2 protein co-treated with hydroquinone] results in increased phosphorylation of and results in increased activity of MAPK1 protein | 15129224 |
| C031927 | hydroquinone | [CSF2 protein co-treated with hydroquinone] results in increased phosphorylation of and results in increased activity of MAPK3 protein | 15129224 |
| C031927 | hydroquinone | hydroquinone promotes the reaction [[CSF2 protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide] | 7884313 |
| C013038 | hydroxyhydroquinone | hydroxyhydroquinone promotes the reaction [[CSF2 protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide] | 7884313 |
| C477872 | IC 87114 | IC 87114 inhibits the reaction [PTPN11 protein mutant form results in increased susceptibility to CSF2 protein] | 22315502 |
| C477872 | IC 87114 | IC 87114 results in decreased susceptibility to CSF2 protein | 22315502 |
| D007213 | Indomethacin | Indomethacin results in increased expression of CSF2 mRNA | 16984733 |
| D015759 | Ionomycin | [Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of CSF2 protein | 17685462 |
| D015759 | Ionomycin | sodium bichromate inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of CSF2 protein] | 17685462 |
| D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CSF2 protein | 17572062 |
| D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CSF2 mRNA | 25613284 |
| D007501 | Iron | [Nickel co-treated with Iron co-treated with Tungsten] results in increased expression of CSF2 mRNA | 22198552 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 mRNA] | 25725100 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in decreased expression of CSF2 mRNA | 24796395|2530787 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound inhibits the reaction [[KRAS mutant form co-treated with TRP53 mutant form] results in increased expression of CSF2 protein] | 26390243 |
| C006552 | kaempferol | "1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [kaempferol results in increased secretion of CSF2 protein]" | 18346843 |
| C006552 | kaempferol | "1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [kaempferol results in increased secretion of CSF2 protein]" | 18346843 |
| C006552 | kaempferol | bisindolylmaleimide I inhibits the reaction [kaempferol results in increased secretion of CSF2 protein] | 18346843 |
| C006552 | kaempferol | Brefeldin A inhibits the reaction [kaempferol results in increased secretion of CSF2 protein] | 18346843 |
| C006552 | kaempferol | Colchicine inhibits the reaction [kaempferol results in increased secretion of CSF2 protein] | 18346843 |
| C006552 | kaempferol | Cytochalasin B inhibits the reaction [kaempferol results in increased secretion of CSF2 protein] | 18346843 |
| C006552 | kaempferol | Egtazic Acid inhibits the reaction [kaempferol results in increased secretion of CSF2 protein] | 18346843 |
| C006552 | kaempferol | kaempferol results in increased secretion of CSF2 protein | 18346843 |
| C006552 | kaempferol | Monensin inhibits the reaction [kaempferol results in increased secretion of CSF2 protein] | 18346843 |
| C006552 | kaempferol | Nocodazole inhibits the reaction [kaempferol results in increased secretion of CSF2 protein] | 18346843 |
| C006552 | kaempferol | U 0126 inhibits the reaction [kaempferol results in increased secretion of CSF2 protein] | 18346843 |
| D007854 | Lead | [Lead co-treated with CSF2 protein] results in decreased expression of ITGAX protein | 17512567 |
| D007854 | Lead | Lead results in increased expression of and results in increased secretion of CSF2 protein | 28973681 |
| C008261 | lead acetate | [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of CD40 protein | 17512567 |
| C008261 | lead acetate | [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of CD80 protein | 17512567 |
| C008261 | lead acetate | [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of CD86 protein | 17512567 |
| C008261 | lead acetate | [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of H2 protein | 17512567 |
| C008261 | lead acetate | [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of ICAM1 protein | 17512567 |
| C008261 | lead acetate | [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of IL10 protein | 17512567 |
| C008261 | lead acetate | [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of IL6 protein | 17512567 |
| C008261 | lead acetate | [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of TNF protein | 17512567 |
| C050016 | lipoarabinomannan | CSF2 protein promotes the reaction [lipoarabinomannan results in increased secretion of CXCL8 protein] | 12176910 |
| C433788 | lipopolysaccharide, E. coli O26-B6 | "lipopolysaccharide, E. coli O26-B6 results in increased expression of CSF2 mRNA" | 23090859 |
| C482199 | lipopolysaccharide, E coli O55-B5 | "lipopolysaccharide, E coli O55-B5 inhibits the reaction [Croton Oil results in increased expression of CSF2 protein]" | 8006454 |
| C482199 | lipopolysaccharide, E coli O55-B5 | "lipopolysaccharide, E coli O55-B5 results in increased expression of CSF2 protein" | 23604539 |
| D008070 | Lipopolysaccharides | "15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 mRNA]" | 12604364 |
| D008070 | Lipopolysaccharides | "2,2',4,4'-tetrabromodiphenyl ether inhibits the reaction [Lipopolysaccharides results in increased secretion of CSF2 protein]" | 19211157 |
| D008070 | Lipopolysaccharides | coagulin-L inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 protein] | 27568862 |
| D008070 | Lipopolysaccharides | [CSF1 protein co-treated with CSF2 protein] promotes the reaction [Lipopolysaccharides results in increased chemical synthesis of Nitric Oxide] | 8193360 |
| D008070 | Lipopolysaccharides | CSF2 protein affects the reaction [Lipopolysaccharides results in increased expression of CD80 protein] | 25725100 |
| D008070 | Lipopolysaccharides | CSF2 protein affects the reaction [Lipopolysaccharides results in increased expression of CD83 protein] | 25725100 |
| D008070 | Lipopolysaccharides | CSF2 protein affects the reaction [Lipopolysaccharides results in increased expression of CD86 protein] | 25725100 |
| D008070 | Lipopolysaccharides | CSF2 protein affects the reaction [Lipopolysaccharides results in increased phosphorylation of STAT5A protein] | 25725100 |
| D008070 | Lipopolysaccharides | CSF2 protein affects the reaction [Lipopolysaccharides results in increased phosphorylation of STAT5B protein] | 25725100 |
| D008070 | Lipopolysaccharides | CSF2 protein promotes the reaction [Lipopolysaccharides results in increased secretion of CXCL8 protein] | 12176910 |
| D008070 | Lipopolysaccharides | Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 protein] | 27568862 |
| D008070 | Lipopolysaccharides | (+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 mRNA] | 25725100 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides affects the expression of CSF2 mRNA | 28070326 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CSF2 protein | 17051331 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides inhibits the reaction [[CSF2 protein co-treated with IL4 protein] results in increased expression of CD1A protein] | 18390722 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides promotes the reaction [[CSF2 protein co-treated with IL4 protein] results in increased expression of TFRC protein] | 18390722 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of CSF2 mRNA | 12604364|2154030 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of CSF2 protein | 18684396|2135258 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased secretion of CSF2 protein | 15191912|1761850 |
| D008070 | Lipopolysaccharides | phenethyl isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 mRNA] | 23724058 |
| D008070 | Lipopolysaccharides | Plant Extracts affects the reaction [Lipopolysaccharides affects the expression of CSF2 mRNA] | 28070326 |
| D008070 | Lipopolysaccharides | resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 protein] | 24707119 |
| D008070 | Lipopolysaccharides | Silymarin inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 protein] | 24707119 |
| D008070 | Lipopolysaccharides | Spironolactone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] results in increased expression of CSF2 protein] | 17051331 |
| D008070 | Lipopolysaccharides | Sulfasalazine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] results in increased expression of CSF2 protein] | 17051331 |
| D008070 | Lipopolysaccharides | Triclosan inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 mRNA] | 20507366 |
| D008070 | Lipopolysaccharides | [usnic acid co-treated with Lipopolysaccharides] results in decreased expression of CSF2 mRNA | 22777745 |
| D008070 | Lipopolysaccharides | "1,3-dimethylthiourea inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 protein]" | 11752025 |
| D008070 | Lipopolysaccharides | "3,4-dihydroxybenzohydroxamic acid inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 mRNA]" | 25843059 |
| D008070 | Lipopolysaccharides | [Benzene co-treated with Enzyme Inhibitors] promotes the reaction [[Lipopolysaccharides co-treated with CSF2 protein] results in increased chemical synthesis of Nitric Oxide] | 8193360 |
| D008070 | Lipopolysaccharides | Benzene promotes the reaction [[CSF2 protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide] | 7884313 |
| D008070 | Lipopolysaccharides | Benzene promotes the reaction [[Lipopolysaccharides co-treated with CSF2 protein] results in increased chemical synthesis of Nitric Oxide] | 8193360 |
| D008070 | Lipopolysaccharides | Benzene promotes the reaction [[[Lipopolysaccharides co-treated with IFNG protein] co-treated with CSF2 protein] results in increased chemical synthesis of Nitric Oxide] | 8193360 |
| D008070 | Lipopolysaccharides | coagulin-L inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 protein] | 27568862 |
| D008070 | Lipopolysaccharides | [CSF2 protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide | 7884313 |
| D008070 | Lipopolysaccharides | cyanoginosin LR inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 mRNA] | 15712326 |
| D008070 | Lipopolysaccharides | Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 mRNA] | 16880258 |
| D008070 | Lipopolysaccharides | Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 protein] | 27568862 |
| D008070 | Lipopolysaccharides | E804 bisindole inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 mRNA] | 23107598 |
| D008070 | Lipopolysaccharides | Enzyme Inhibitors results in increased susceptibility to [Lipopolysaccharides co-treated with CSF2 protein] | 8193360 |
| D008070 | Lipopolysaccharides | GLRX protein promotes the reaction [Lipopolysaccharides results in increased expression of CSF2 protein] | 20539014 |
| D008070 | Lipopolysaccharides | hydroquinone promotes the reaction [[CSF2 protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide] | 7884313 |
| D008070 | Lipopolysaccharides | hydroxyhydroquinone promotes the reaction [[CSF2 protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide] | 7884313 |
| D008070 | Lipopolysaccharides | IL6 protein affects the reaction [Lipopolysaccharides results in increased secretion of CSF2 protein] | 15804595 |
| D008070 | Lipopolysaccharides | LCN2 protein inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 mRNA] | 18292240 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with CSF2 protein] results in increased chemical synthesis of Nitric Oxide | 8193360 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with CSF2 protein] results in increased expression of CD40 protein | 17512567 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with CSF2 protein] results in increased expression of CD80 protein | 17512567 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with CSF2 protein] results in increased expression of CD86 protein | 17512567 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with CSF2 protein] results in increased expression of H2 protein | 17512567 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with CSF2 protein] results in increased expression of ICAM1 protein | 17512567 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with CSF2 protein] results in increased expression of IL10 protein | 17512567 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with CSF2 protein] results in increased expression of IL6 protein | 17512567 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with CSF2 protein] results in increased expression of TNF protein | 17512567 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CSF2 mRNA | 15222974 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CSF2 protein | 15135318 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of CD40 protein | 17512567 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of CD80 protein | 17512567 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of CD86 protein | 17512567 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of H2 protein | 17512567 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of ICAM1 protein | 17512567 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of IL10 protein | 17512567 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of IL6 protein | 17512567 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of TNF protein | 17512567 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides inhibits the reaction [E804 bisindole results in increased expression of CSF2 mRNA] | 23107598 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in decreased susceptibility to CSF2 protein | 8193360 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of CSF2 mRNA | 15712326|1688025 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of CSF2 protein | 11752025|1902077 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased secretion of CSF2 protein | 19339665|2373548 |
| D008070 | Lipopolysaccharides | Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CSF2 mRNA] | 15222974 |
| D008070 | Lipopolysaccharides | mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CSF2 protein] | 15135318 |
| D008070 | Lipopolysaccharides | methyldithiocarbamate inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 mRNA] | 24056979 |
| D008070 | Lipopolysaccharides | methyldithiocarbamate inhibits the reaction [Lipopolysaccharides results in increased secretion of CSF2 protein] | 19339665|2405697 |
| D008070 | Lipopolysaccharides | phenethyl isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 mRNA] | 20423518 |
| D008070 | Lipopolysaccharides | [procyanidin B3 co-treated with Eicosapentaenoic Acid] inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 mRNA] | 22169119 |
| D008070 | Lipopolysaccharides | Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 mRNA] | 23735482 |
| D008070 | Lipopolysaccharides | Quercetin inhibits the reaction [Lipopolysaccharides results in increased secretion of CSF2 protein] | 23735482 |
| D008070 | Lipopolysaccharides | quinone promotes the reaction [[CSF2 protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide] | 7884313 |
| D008070 | Lipopolysaccharides | terameprocol inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 protein] | 19133137 |
| D008070 | Lipopolysaccharides | [Zymosan co-treated with Lipopolysaccharides] results in increased expression of CSF2 protein | 16192389 |
| D008070 | Lipopolysaccharides | [IL3 protein co-treated with CSF1 protein co-treated with CSF2 protein] promotes the reaction [Lipopolysaccharides results in increased chemical synthesis of Nitric Oxide] | 8193360 |
| D008070 | Lipopolysaccharides | [IL3 protein co-treated with CSF2 protein] promotes the reaction [Lipopolysaccharides results in increased chemical synthesis of Nitric Oxide] | 8193360 |
| C009900 | lipoteichoic acid | Dexamethasone inhibits the reaction [lipoteichoic acid results in increased secretion of CSF2 protein] | 23981542 |
| C009900 | lipoteichoic acid | lipoteichoic acid results in increased secretion of CSF2 protein | 23981542 |
| C009900 | lipoteichoic acid | resveratrol inhibits the reaction [lipoteichoic acid results in increased secretion of CSF2 protein] | 23981542 |
| D017998 | Leukotriene D4 | Leukotriene D4 promotes the reaction [CSF2 protein results in increased expression of TGFB1 protein] | 15947480 |
| D047311 | Luteolin | Luteolin results in decreased expression of CSF2 mRNA | 10718847 |
| D047311 | Luteolin | Luteolin inhibits the reaction [Calcimycin results in increased expression of CSF2 mRNA] | 17950587 |
| C025340 | manganese chloride | manganese chloride promotes the reaction [SNCA protein results in increased expression of CSF2 mRNA] | 28539244 |
| C501277 | Mangifera indica extract | Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CSF2 mRNA] | 15222974 |
| C013592 | mangiferin | mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CSF2 protein] | 15135318 |
| C013592 | mangiferin | mangiferin results in decreased expression of CSF2 mRNA | 15135318 |
| D008627 | Mercuric Chloride | Mercuric Chloride results in increased expression of CSF2 protein | 21984480 |
| D000432 | Methanol | Methanol results in increased expression of CSF2 protein | 11306435 |
| C067472 | methyl 2,5-dihydroxycinnamate | "CSF2 protein affects the susceptibility to [Nitroblue Tetrazolium co-treated with methyl 2,5-dihydroxycinnamate]" | 8471626 |
| C008435 | methyldithiocarbamate | methyldithiocarbamate inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 mRNA] | 24056979 |
| C008435 | methyldithiocarbamate | methyldithiocarbamate inhibits the reaction [Lipopolysaccharides results in increased secretion of CSF2 protein] | 19339665|2405697 |
| D008770 | Methylnitrosourea | Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of CSF2 protein] | 16822543 |
| D008770 | Methylnitrosourea | Freund's Adjuvant inhibits the reaction [Methylnitrosourea results in increased expression of CSF2 protein] | 16822543 |
| D008770 | Methylnitrosourea | IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of CSF2 protein] | 16822543 |
| D008770 | Methylnitrosourea | Methylnitrosourea results in increased expression of CSF2 protein | 16822543 |
| C089950 | MF59 oil emulsion | MF59 oil emulsion inhibits the reaction [[CSF2 protein co-treated with IL4 protein] results in increased expression of CD1A protein] | 18390722 |
| C089950 | MF59 oil emulsion | MF59 oil emulsion inhibits the reaction [[CSF2 protein co-treated with IL4 protein] results in increased expression of CD80 protein] | 18390722 |
| C089950 | MF59 oil emulsion | MF59 oil emulsion promotes the reaction [[CSF2 protein co-treated with IL4 protein] results in decreased expression of CD14 protein] | 18390722 |
| C089950 | MF59 oil emulsion | MF59 oil emulsion promotes the reaction [[CSF2 protein co-treated with IL4 protein] results in increased expression of CCR7 protein] | 18390722 |
| C089950 | MF59 oil emulsion | MF59 oil emulsion promotes the reaction [[CSF2 protein co-treated with IL4 protein] results in increased expression of CD83 protein] | 18390722 |
| C089950 | MF59 oil emulsion | MF59 oil emulsion promotes the reaction [[CSF2 protein co-treated with IL4 protein] results in increased expression of CD86 protein] | 18390722 |
| C089950 | MF59 oil emulsion | MF59 oil emulsion promotes the reaction [[CSF2 protein co-treated with IL4 protein] results in increased expression of TFRC protein] | 18390722 |
| C089950 | MF59 oil emulsion | MF59 oil emulsion promotes the reaction [CSF2 protein results in decreased expression of CD14 protein] | 18390722 |
| C089950 | MF59 oil emulsion | MF59 oil emulsion promotes the reaction [CSF2 protein results in increased expression of CD86 protein] | 18390722 |
| C070571 | ML 7 | ML 7 affects the activity of CSF2 protein | 8471626 |
| C056218 | ML 9 | ML 9 affects the activity of CSF2 protein | 8471626 |
| D000068656 | Mometasone Furoate | Mometasone Furoate inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein] | 10460758 |
| D008985 | Monensin | Monensin inhibits the reaction [kaempferol results in increased secretion of CSF2 protein] | 18346843 |
| D008985 | Monensin | Monensin inhibits the reaction [Quercetin results in increased secretion of CSF2 protein] | 18346843 |
| C406082 | monomethylarsonous acid | monomethylarsonous acid results in increased expression of CSF2 mRNA | 20886546 |
| D009151 | Mustard Gas | Mustard Gas results in increased expression of CSF2 mRNA | 25102026 |
| D009151 | Mustard Gas | Mustard Gas results in increased expression of CSF2 protein | 17894541 |
| D009151 | Mustard Gas | Mustard Gas results in increased expression of CSF2 mRNA | 11083082 |
| D009151 | Mustard Gas | Mustard Gas results in increased expression of CSF2 protein | 11083082 |
| C078131 | N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide | N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide inhibits the reaction [Particulate Matter results in increased secretion of CSF2 protein] | 22581348 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in decreased expression of CSF2 mRNA" | 23634900 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in increased expression of CSF2 mRNA" | 24389112 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in increased expression of CSF2 mRNA" | 25554681 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in increased expression of CSF2 mRNA" | 25554681 |
| D009288 | Naproxen | [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CSF2 protein] | 22150557 |
| D009288 | Naproxen | Naproxen inhibits the reaction [Capsaicin results in increased expression of CSF2 protein] | 22150557 |
| D009532 | Nickel | [Nickel co-treated with Cobalt co-treated with Tungsten] results in increased expression of CSF2 mRNA | 22198552 |
| D009532 | Nickel | [Nickel co-treated with Iron co-treated with Tungsten] results in increased expression of CSF2 mRNA | 22198552 |
| C022838 | nickel chloride | nickel chloride results in increased expression of CSF2 mRNA | 17312168 |
| C022838 | nickel chloride | nickel chloride results in increased expression of CSF2 protein | 21569788 |
| C022838 | nickel chloride | nickel chloride affects the expression of CSF2 mRNA | 24670797 |
| D009538 | Nicotine | Nicotine results in increased expression of and results in increased secretion of CSF2 protein | 18082304 |
| D009538 | Nicotine | Nicotine results in increased secretion of CSF2 protein | 9606035 |
| D009538 | Nicotine | Tubocurarine inhibits the reaction [Nicotine results in increased secretion of CSF2 protein] | 9606035 |
| D009569 | Nitric Oxide | [CSF1 protein co-treated with CSF2 protein] promotes the reaction [Lipopolysaccharides results in increased chemical synthesis of Nitric Oxide] | 8193360 |
| D009569 | Nitric Oxide | [Benzene co-treated with Enzyme Inhibitors] promotes the reaction [[Lipopolysaccharides co-treated with CSF2 protein] results in increased chemical synthesis of Nitric Oxide] | 8193360 |
| D009569 | Nitric Oxide | Benzene promotes the reaction [[CSF2 protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide] | 7884313 |
| D009569 | Nitric Oxide | Benzene promotes the reaction [[Lipopolysaccharides co-treated with CSF2 protein] results in increased chemical synthesis of Nitric Oxide] | 8193360 |
| D009569 | Nitric Oxide | Benzene promotes the reaction [[[Lipopolysaccharides co-treated with IFNG protein] co-treated with CSF2 protein] results in increased chemical synthesis of Nitric Oxide] | 8193360 |
| D009569 | Nitric Oxide | [CSF2 protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide | 7884313 |
| D009569 | Nitric Oxide | hydroquinone promotes the reaction [[CSF2 protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide] | 7884313 |
| D009569 | Nitric Oxide | hydroxyhydroquinone promotes the reaction [[CSF2 protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide] | 7884313 |
| D009569 | Nitric Oxide | [Lipopolysaccharides co-treated with CSF2 protein] results in increased chemical synthesis of Nitric Oxide | 8193360 |
| D009569 | Nitric Oxide | quinone promotes the reaction [[CSF2 protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide] | 7884313 |
| D009569 | Nitric Oxide | CSF2 protein promotes the reaction [ITGB2 protein results in increased abundance of Nitric Oxide] | 8600936 |
| D009569 | Nitric Oxide | [CSF2 protein results in increased expression of ITGB2 protein] which results in increased abundance of Nitric Oxide | 8600936 |
| D009569 | Nitric Oxide | Ozone promotes the reaction [[CSF2 protein results in increased expression of ITGB2 protein] which results in increased abundance of Nitric Oxide] | 8600936 |
| D009569 | Nitric Oxide | [IL3 protein co-treated with CSF1 protein co-treated with CSF2 protein] promotes the reaction [Lipopolysaccharides results in increased chemical synthesis of Nitric Oxide] | 8193360 |
| D009569 | Nitric Oxide | [IL3 protein co-treated with CSF2 protein] promotes the reaction [Lipopolysaccharides results in increased chemical synthesis of Nitric Oxide] | 8193360 |
| D009569 | Nitric Oxide | Nitric Oxide results in decreased activity of CSF2 protein | 8193360 |
| D009573 | Nitrites | CSF2 protein results in decreased abundance of Nitrites | 10802225 |
| D009580 | Nitroblue Tetrazolium | CSF2 protein affects the susceptibility to Nitroblue Tetrazolium | 8471626 |
| D009580 | Nitroblue Tetrazolium | "CSF2 protein affects the susceptibility to [Nitroblue Tetrazolium co-treated with methyl 2,5-dihydroxycinnamate]" | 8471626 |
| D009580 | Nitroblue Tetrazolium | CSF2 protein affects the susceptibility to [Nitroblue Tetrazolium co-treated with psi-tectorigenin] | 8471626 |
| D009580 | Nitroblue Tetrazolium | CSF2 protein affects the susceptibility to [Nitroblue Tetrazolium co-treated with Staurosporine] | 8471626 |
| D009585 | Nitrogen Dioxide | Nitrogen Dioxide results in increased secretion of CSF2 protein | 8398164 |
| D015112 | 4-Nitroquinoline-1-oxide | 4-Nitroquinoline-1-oxide results in increased expression of CSF2 mRNA | 22561872 |
| D015739 | Nocodazole | Nocodazole inhibits the reaction [kaempferol results in increased secretion of CSF2 protein] | 18346843 |
| D015739 | Nocodazole | Nocodazole inhibits the reaction [Quercetin results in increased secretion of CSF2 protein] | 18346843 |
| C434926 | N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride | "N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [zinc chloride results in increased expression of CSF2 protein]" | 18509044 |
| D009942 | Organometallic Compounds | [Organometallic Compounds co-treated with Cobalt] results in increased expression of CSF2 mRNA | 22147119 |
| D010081 | Oxazolone | Oxazolone results in increased expression of CSF2 mRNA | 18652873 |
| D010126 | Ozone | Ozone results in increased expression of CSF2 protein | 18315731 |
| D010126 | Ozone | Ozone promotes the reaction [[CSF2 protein results in increased expression of ITGB2 protein] which results in increased abundance of Nitric Oxide] | 8600936 |
| D010126 | Ozone | Ozone results in decreased expression of CSF2 mRNA | 16330353 |
| D010269 | Paraquat | Paraquat results in increased expression of CSF2 mRNA | 22938100 |
| D052638 | Particulate Matter | "1,3-dimethylthiourea inhibits the reaction [Particulate Matter results in increased secretion of CSF2 protein]" | 10645887 |
| D052638 | Particulate Matter | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Particulate Matter results in increased secretion of CSF2 protein] | 10645887|1946041 |
| D052638 | Particulate Matter | Acetylcysteine inhibits the reaction [Particulate Matter analog results in increased secretion of CSF2 protein] | 10645887 |
| D052638 | Particulate Matter | Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of CSF2 protein] | 10645887|1946041 |
| D052638 | Particulate Matter | ADAM17 mutant form inhibits the reaction [Particulate Matter results in increased secretion of CSF2 protein] | 22581348 |
| D052638 | Particulate Matter | alpha-naphthoflavone inhibits the reaction [Particulate Matter results in increased expression of CSF2 mRNA] | 20801209 |
| D052638 | Particulate Matter | Atorvastatin Calcium inhibits the reaction [Particulate Matter results in increased expression of CSF2 mRNA] | 19482827 |
| D052638 | Particulate Matter | Atorvastatin Calcium inhibits the reaction [Particulate Matter results in increased expression of CSF2 protein] | 19482827 |
| D052638 | Particulate Matter | CAT protein inhibits the reaction [Particulate Matter results in increased expression of CSF2 mRNA] | 21703343 |
| D052638 | Particulate Matter | CAT protein inhibits the reaction [Particulate Matter results in increased secretion of CSF2 protein] | 19460412 |
| D052638 | Particulate Matter | Cycloheximide inhibits the reaction [Particulate Matter results in increased secretion of CSF2 protein] | 10645887 |
| D052638 | Particulate Matter | Cytochalasin D inhibits the reaction [Particulate Matter results in increased secretion of CSF2 protein] | 10645887 |
| D052638 | Particulate Matter | Dactinomycin inhibits the reaction [Particulate Matter results in increased secretion of CSF2 protein] | 10645887 |
| D052638 | Particulate Matter | Deferoxamine inhibits the reaction [Particulate Matter results in increased expression of CSF2 mRNA] | 20801209|2170334 |
| D052638 | Particulate Matter | Genistein inhibits the reaction [Particulate Matter results in increased secretion of CSF2 protein] | 10645887 |
| D052638 | Particulate Matter | N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide inhibits the reaction [Particulate Matter results in increased secretion of CSF2 protein] | 22581348 |
| D052638 | Particulate Matter | Particulate Matter analog promotes the reaction [Histamine results in increased secretion of CSF2 protein] | 10051702 |
| D052638 | Particulate Matter | Particulate Matter analog results in increased secretion of CSF2 protein | 10645887|1169445 |
| D052638 | Particulate Matter | Particulate Matter results in decreased expression of CSF2 protein | 28189646 |
| D052638 | Particulate Matter | Particulate Matter results in increased expression of CSF2 mRNA | 10645887|1948282 |
| D052638 | Particulate Matter | Particulate Matter results in increased expression of CSF2 protein | 19482827 |
| D052638 | Particulate Matter | Particulate Matter results in increased secretion of CSF2 protein | 10645887|1169445 |
| D052638 | Particulate Matter | prolinedithiocarbamate inhibits the reaction [Particulate Matter results in increased secretion of CSF2 protein] | 10645887 |
| D052638 | Particulate Matter | pyrazolanthrone inhibits the reaction [Particulate Matter results in increased secretion of CSF2 protein] | 19460412 |
| D052638 | Particulate Matter | SB 203580 inhibits the reaction [Particulate Matter results in increased secretion of CSF2 protein] | 10645887 |
| D052638 | Particulate Matter | TAPI-2 inhibits the reaction [Particulate Matter results in increased secretion of CSF2 protein] | 22581348 |
| D052638 | Particulate Matter | tyrphostin AG 1478 inhibits the reaction [Particulate Matter results in increased secretion of CSF2 protein] | 19460412|2258134 |
| D052638 | Particulate Matter | CSF2 protein results in increased susceptibility to Particulate Matter | 10550748 |
| D052638 | Particulate Matter | Particulate Matter results in decreased expression of CSF2 mRNA | 23638009 |
| D052638 | Particulate Matter | Particulate Matter results in increased expression of CSF2 mRNA | 10550748|2170821 |
| D052638 | Particulate Matter | Particulate Matter results in increased secretion of CSF2 protein | 23962744 |
| D052638 | Particulate Matter | Particulate Matter results in increased expression of CSF2 mRNA | 24216475 |
| D010396 | Penicillamine | Penicillamine results in increased expression of CSF2 mRNA | 19575532 |
| D010416 | Pentachlorophenol | Pentachlorophenol results in increased expression of CSF2 mRNA | 23892564 |
| C046012 | pentanal | pentanal analog affects the expression of CSF2 mRNA | 20200221 |
| D010457 | Peptidoglycan | CSF2 protein promotes the reaction [Peptidoglycan results in increased secretion of CXCL8 protein] | 12176910 |
| D010457 | Peptidoglycan | Peptidoglycan results in increased expression of CSF2 mRNA | 15191912 |
| D010457 | Peptidoglycan | Peptidoglycan results in increased expression of CSF2 protein | 12574323 |
| D026023 | Permethrin | [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of CSF2 mRNA | 28659758 |
| D015232 | Dinoprostone | [IL4 protein co-treated with CSF2 protein co-treated with TNF protein co-treated with Dinoprostone co-treated with IL1B protein co-treated with IL6 protein] results in increased expression of CCR7 protein | 18952292 |
| D015232 | Dinoprostone | [IL4 protein co-treated with CSF2 protein co-treated with TNF protein co-treated with Dinoprostone co-treated with IL1B protein co-treated with IL6 protein] results in increased expression of MUC1 protein | 18952292 |
| D015232 | Dinoprostone | CSF2 protein promotes the reaction [Dinoprostone results in increased expression of [IL12B protein binds to IL23A protein]] | 15180965 |
| C058305 | phenethyl isothiocyanate | phenethyl isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 mRNA] | 23724058 |
| C058305 | phenethyl isothiocyanate | phenethyl isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 mRNA] | 20423518 |
| C016657 | phomenone | phomenone results in increased expression of and results in increased secretion of CSF2 protein | 28535995 |
| D010795 | Phthalic Acids | Phthalic Acids results in decreased expression of CSF2 mRNA | 21061450 |
| D010862 | Pilocarpine | Pilocarpine results in decreased expression of CSF2 mRNA | 17971868 |
| D010862 | Pilocarpine | Pilocarpine results in increased expression of CSF2 mRNA | 17971868 |
| C117268 | pimecrolimus | pimecrolimus results in increased secretion of CSF2 protein | 15086553 |
| C008922 | piperine | piperine results in decreased expression of CSF2 mRNA | 15531295 |
| C008922 | piperine | piperine results in decreased secretion of CSF2 protein | 15531295 |
| D010936 | Plant Extracts | Plant Extracts affects the reaction [Lipopolysaccharides affects the expression of CSF2 mRNA] | 28070326 |
| C531249 | Poly(amidoamine) | Poly(amidoamine) analog results in decreased expression of CSF2 mRNA | 23806026 |
| D020959 | Polyethylene | Polyethylene affects the secretion of CSF2 protein | 15046894 |
| D011070 | Poly I-C | Ethanol inhibits the reaction [Poly I-C results in increased expression of CSF2 protein] | 19500611 |
| D011070 | Poly I-C | Poly I-C results in increased expression of CSF2 protein | 19500611 |
| C467566 | pomalidomide | pomalidomide results in decreased secretion of CSF2 protein | 15292067 |
| C479581 | procyanidin B3 | [procyanidin B3 co-treated with Eicosapentaenoic Acid] inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 mRNA] | 22169119 |
| C066229 | prolinedithiocarbamate | prolinedithiocarbamate inhibits the reaction [Particulate Matter results in increased secretion of CSF2 protein] | 10645887 |
| C066229 | prolinedithiocarbamate | prolinedithiocarbamate inhibits the reaction [Vehicle Emissions results in increased secretion of CSF2 protein] | 10645887 |
| D019840 | 2-Propanol | 2-Propanol results in increased secretion of CSF2 protein | 22245253 |
| C055439 | psi-tectorigenin | CSF2 protein affects the susceptibility to [Nitroblue Tetrazolium co-treated with psi-tectorigenin] | 8471626 |
| C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [Particulate Matter results in increased secretion of CSF2 protein] | 19460412 |
| D011729 | Pyridostigmine Bromide | [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of CSF2 mRNA | 28659758 |
| D011791 | Quartz | Quartz results in increased expression of CSF2 mRNA | 27917503 |
| D011794 | Quercetin | "1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Quercetin results in increased secretion of CSF2 protein]" | 18346843 |
| D011794 | Quercetin | "1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [Quercetin results in increased secretion of CSF2 protein]" | 18346843 |
| D011794 | Quercetin | bisindolylmaleimide I inhibits the reaction [Quercetin results in increased secretion of CSF2 protein] | 18346843 |
| D011794 | Quercetin | Brefeldin A inhibits the reaction [Quercetin results in increased secretion of CSF2 protein] | 18346843 |
| D011794 | Quercetin | Colchicine inhibits the reaction [Quercetin results in increased secretion of CSF2 protein] | 18346843 |
| D011794 | Quercetin | Cytochalasin B inhibits the reaction [Quercetin results in increased secretion of CSF2 protein] | 18346843 |
| D011794 | Quercetin | Egtazic Acid inhibits the reaction [Quercetin results in increased secretion of CSF2 protein] | 18346843 |
| D011794 | Quercetin | Monensin inhibits the reaction [Quercetin results in increased secretion of CSF2 protein] | 18346843 |
| D011794 | Quercetin | Nocodazole inhibits the reaction [Quercetin results in increased secretion of CSF2 protein] | 18346843 |
| D011794 | Quercetin | Quercetin inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein] | 15180920 |
| D011794 | Quercetin | Quercetin results in decreased expression of CSF2 mRNA | 10718847 |
| D011794 | Quercetin | Quercetin results in increased secretion of CSF2 protein | 18346843 |
| D011794 | Quercetin | U 0126 inhibits the reaction [Quercetin results in increased secretion of CSF2 protein] | 18346843 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 mRNA] | 23735482 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Lipopolysaccharides results in increased secretion of CSF2 protein] | 23735482 |
| C004532 | quinone | quinone promotes the reaction [[CSF2 protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide] | 7884313 |
| D020849 | Raloxifene Hydrochloride | [Raloxifene Hydrochloride co-treated with ESR1 protein] results in decreased expression of CSF2 mRNA | 19059307 |
| D017382 | Reactive Oxygen Species | "1,3-dimethylthiourea inhibits the reaction [Reactive Oxygen Species results in increased expression of CSF2 protein]" | 11752025 |
| D017382 | Reactive Oxygen Species | Dactinomycin inhibits the reaction [Reactive Oxygen Species results in increased expression of CSF2 protein] | 11752025 |
| D017382 | Reactive Oxygen Species | [NAD results in increased abundance of Reactive Oxygen Species] which results in increased expression of CSF2 protein | 11752025 |
| D017382 | Reactive Oxygen Species | Reactive Oxygen Species results in increased expression of CSF2 mRNA | 11752025 |
| D017382 | Reactive Oxygen Species | Reactive Oxygen Species results in increased expression of CSF2 protein | 11752025 |
| D017382 | Reactive Oxygen Species | Thiocarbamates inhibits the reaction [Reactive Oxygen Species results in increased expression of CSF2 protein] | 11752025 |
| C059514 | resveratrol | resveratrol inhibits the reaction [7-ketocholesterol results in increased expression of CSF2 protein] | 24895526 |
| C059514 | resveratrol | resveratrol inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein] | 15180920 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 protein] | 24707119 |
| C059514 | resveratrol | resveratrol inhibits the reaction [lipoteichoic acid results in increased secretion of CSF2 protein] | 23981542 |
| C059514 | resveratrol | resveratrol inhibits the reaction [TNF protein results in increased secretion of CSF2 protein] | 20801891 |
| C059514 | resveratrol | resveratrol results in increased expression of CSF2 mRNA | 15280659 |
| C059514 | resveratrol | resveratrol analog results in decreased expression of CSF2 mRNA | 15652768 |
| D015474 | Isotretinoin | Isotretinoin results in decreased secretion of CSF2 protein | 15972972 |
| D015474 | Isotretinoin | Isotretinoin results in increased expression of CSF2 protein | 19066126 |
| C034206 | Ribomunyl | [IL13 protein co-treated with CSF2 protein co-treated with Ribomunyl co-treated with IFNG protein] results in increased expression of CCR7 protein | 18952292 |
| C034206 | Ribomunyl | [IL13 protein co-treated with CSF2 protein co-treated with Ribomunyl co-treated with IFNG protein] results in increased expression of MUC1 protein | 18952292 |
| D012431 | Rutin | Rutin inhibits the reaction [Dextran Sulfate results in increased expression of CSF2 mRNA] | 15652231 |
| D000068299 | Salmeterol Xinafoate | "Salmeterol Xinafoate inhibits the reaction [Antigens, Dermatophagoides results in increased secretion of CSF2 protein]" | 9344832 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [Particulate Matter results in increased secretion of CSF2 protein] | 10645887 |
| C093642 | SB 203580 | "SB 203580 inhibits the reaction [[Toluene 2,4-Diisocyanate binds to ALB protein] which results in increased expression of CSF2 protein]" | 16908450 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [Vehicle Emissions results in increased secretion of CSF2 protein] | 10645887 |
| D012601 | Scopolamine Hydrobromide | CSF2 protein results in decreased susceptibility to Scopolamine Hydrobromide | 8877002 |
| D012601 | Scopolamine Hydrobromide | IL1RN protein inhibits the reaction [CSF2 protein results in decreased susceptibility to Scopolamine Hydrobromide] | 8877002 |
| D017632 | Asbestos, Serpentine | "Asbestos, Serpentine results in increased expression of CSF2 mRNA" | 24160326 |
| D017632 | Asbestos, Serpentine | "[Asbestos, Serpentine results in increased secretion of IL1B protein] which results in increased secretion of CSF2 protein" | 23017228 |
| D017632 | Asbestos, Serpentine | "Asbestos, Serpentine results in increased expression of CSF2 protein" | 17200189 |
| D017632 | Asbestos, Serpentine | "PRKDC affects the reaction [Asbestos, Serpentine results in increased expression of CSF2 protein]" | 17200189 |
| D012822 | Silicon Dioxide | Silicon Dioxide analog results in increased expression of CSF2 mRNA | 23806026|2589566 |
| D012822 | Silicon Dioxide | Silicon Dioxide results in increased expression of CSF2 mRNA | 21540303|2230053 |
| D012822 | Silicon Dioxide | [Gold co-treated with Silicon Dioxide] results in increased secretion of CSF2 protein | 22155353 |
| D012822 | Silicon Dioxide | Silicon Dioxide results in increased expression of CSF2 mRNA | 26345256 |
| D012838 | Silymarin | Silymarin inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 protein] | 24707119 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CSF2 protein]] | 1376361 |
| D012906 | Smoke | Smoke results in increased expression of and results in increased secretion of CSF2 protein | 28572013 |
| D012906 | Smoke | Smoke results in increased secretion of CSF2 protein | 17041012 |
| C017947 | sodium arsenite | sodium arsenite inhibits the reaction [[TNF protein co-treated with CSF2 protein] results in increased expression of CD1A protein] | 23164666 |
| C017947 | sodium arsenite | sodium arsenite inhibits the reaction [[TNF protein co-treated with CSF2 protein] results in increased expression of CD209 protein] | 23164666 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of CSF2 mRNA | 21281968|2742724 |
| C017947 | sodium arsenite | sodium arsenite results in increased secretion of CSF2 protein | 8917704|9219559 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of CSF2 mRNA | 9846968 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of CSF2 protein | 9846968 |
| C016104 | sodium bichromate | sodium bichromate inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of CSF2 protein] | 17685462 |
| D012967 | Sodium Dodecyl Sulfate | Sodium Dodecyl Sulfate results in increased expression of CSF2 mRNA | 11378323 |
| D012967 | Sodium Dodecyl Sulfate | Sodium Dodecyl Sulfate results in increased secretion of CSF2 protein | 22245253 |
| C538809 | sodium pentaborate | sodium pentaborate analog results in increased expression of CSF2 protein | 27206737 |
| D053260 | Soot | Soot results in increased expression of CSF2 mRNA | 10645887|1946458 |
| D053260 | Soot | Soot results in increased expression of CSF2 protein | 18684396 |
| D053260 | Soot | Soot results in increased secretion of CSF2 protein | 19464580 |
| D053260 | Soot | Soot results in increased expression of CSF2 mRNA | 19165387|2246145 |
| D013148 | Spironolactone | Spironolactone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] results in increased expression of CSF2 protein] | 17051331 |
| D019311 | Staurosporine | CSF2 protein affects the susceptibility to [Nitroblue Tetrazolium co-treated with Staurosporine] | 8471626 |
| D012460 | Sulfasalazine | Sulfasalazine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] results in increased expression of CSF2 protein] | 17051331 |
| C016766 | sulforafan | sulforafan inhibits the reaction [Vehicle Emissions analog results in increased expression of CSF2 protein] | 16905640 |
| D018170 | Sumatriptan | [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CSF2 protein] | 22150557 |
| D018170 | Sumatriptan | Sumatriptan inhibits the reaction [Capsaicin results in increased expression of CSF2 protein] | 22150557 |
| D016559 | Tacrolimus | Tacrolimus results in decreased expression of CSF2 protein | 11407316 |
| D016559 | Tacrolimus | Sirolimus inhibits the reaction [Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CSF2 protein]] | 1376361 |
| D016559 | Tacrolimus | Tacrolimus inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CSF2 protein] | 1376361 |
| D016559 | Tacrolimus | Tacrolimus results in increased expression of CSF2 mRNA | 23958496 |
| D013629 | Tamoxifen | [Tamoxifen co-treated with ESR1 protein] results in decreased expression of CSF2 mRNA | 19059307 |
| C099410 | TAPI-2 | TAPI-2 inhibits the reaction [Particulate Matter results in increased secretion of CSF2 protein] | 22581348 |
| D013656 | Taurocholic Acid | EGR1 promotes the reaction [Taurocholic Acid results in increased expression of CSF2 mRNA] | 21224055 |
| D013656 | Taurocholic Acid | Taurocholic Acid results in increased expression of CSF2 mRNA | 21224055 |
| C047246 | temozolomide | CSF2 mRNA affects the susceptibility to temozolomide | 16365179 |
| C076852 | terameprocol | terameprocol inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 protein] | 19133137 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of CSF2 mRNA | 21570461 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CSF2 mRNA | 17942748 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CSF2 mRNA | 14678569|1794274 |
| D013755 | Tetradecanoylphorbol Acetate | [Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of CSF2 protein | 17685462 |
| D013755 | Tetradecanoylphorbol Acetate | [Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CSF2 protein | 17051331 |
| D013755 | Tetradecanoylphorbol Acetate | sodium bichromate inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of CSF2 protein] | 17685462 |
| D013755 | Tetradecanoylphorbol Acetate | Spironolactone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] results in increased expression of CSF2 protein] | 17051331 |
| D013755 | Tetradecanoylphorbol Acetate | Sulfasalazine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] results in increased expression of CSF2 protein] | 17051331 |
| D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CSF2 protein | 17572062 |
| D013755 | Tetradecanoylphorbol Acetate | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CSF2 mRNA | 16979875 |
| D013755 | Tetradecanoylphorbol Acetate | "1,3-dimethylthiourea inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CSF2 protein]" | 11752025 |
| D013755 | Tetradecanoylphorbol Acetate | Cyclosporine inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CSF2 protein] | 1376361 |
| D013755 | Tetradecanoylphorbol Acetate | Sirolimus inhibits the reaction [Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CSF2 protein]] | 1376361 |
| D013755 | Tetradecanoylphorbol Acetate | Tacrolimus inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CSF2 protein] | 1376361 |
| D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CSF2 protein | 1376361 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased expression of CSF2 protein | 11752025 |
| D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CSF2 mRNA | 25613284 |
| D013792 | Thalidomide | Thalidomide results in decreased activity of CSF2 protein | 17557286 |
| D013806 | Theophylline | [Theophylline co-treated with Dexamethasone] inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein] | 12070353 |
| D013806 | Theophylline | Theophylline inhibits the reaction [CSF2 protein results in increased expression of EDN1 mRNA] | 10374451 |
| D013806 | Theophylline | Theophylline promotes the reaction [IL1B protein results in increased secretion of CSF2 protein] | 12070353 |
| D013806 | Theophylline | Theophylline results in decreased expression of CSF2 mRNA | 10596698 |
| D013806 | Theophylline | trichostatin A inhibits the reaction [[Theophylline co-treated with Dexamethasone] inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein]] | 12070353 |
| D013859 | Thiocarbamates | Thiocarbamates inhibits the reaction [Reactive Oxygen Species results in increased expression of CSF2 protein] | 11752025 |
| C079056 | thunberginol B | thunberginol B inhibits the reaction [Calcimycin results in increased expression of CSF2 mRNA] | 17950587 |
| D013936 | Thymidine | CSF2 protein results in increased uptake of Thymidine | 8193360 |
| C402769 | tipifarnib | tipifarnib inhibits the reaction [CSF2 protein results in decreased phosphorylation of MAPK1 protein] | 22315502 |
| C402769 | tipifarnib | tipifarnib inhibits the reaction [CSF2 protein results in decreased phosphorylation of MAPK3 protein] | 22315502 |
| C402769 | tipifarnib | tipifarnib inhibits the reaction [CSF2 protein results in increased phosphorylation of AKT1 protein] | 22315502 |
| C402769 | tipifarnib | tipifarnib results in decreased activity of CSF2 protein | 22315502 |
| C009495 | titanium dioxide | titanium dioxide results in increased expression of CSF2 mRNA | 19464580|1969531 |
| C009495 | titanium dioxide | titanium dioxide results in increased secretion of CSF2 protein | 19464580|2000594 |
| C009495 | titanium dioxide | titanium dioxide results in increased expression of CSF2 mRNA | 23557971|2776080 |
| C009495 | titanium dioxide | titanium dioxide results in increased expression of CSF2 protein | 23557971 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in decreased secretion of CSF2 protein | 27404394 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased expression of CSF2 protein | 18684396 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased secretion of CSF2 protein | 27596523 |
| D014028 | Tobacco Smoke Pollution | [APOE gene mutant form affects the susceptibility to Tobacco Smoke Pollution] which results in increased expression of CSF2 mRNA | 24096154 |
| D014028 | Tobacco Smoke Pollution | [APOE gene mutant form affects the susceptibility to Tobacco Smoke Pollution] which results in increased expression of CSF2 protein | 24096154 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution affects the expression of CSF2 mRNA | 20133372 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution deficiency inhibits the reaction [[APOE gene mutant form affects the susceptibility to Tobacco Smoke Pollution] which results in increased expression of CSF2 protein] | 24096154 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased expression of CSF2 mRNA | 21636132 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased expression of CSF2 protein | 21636132 |
| D014051 | Toluene 2,4-Diisocyanate | "Dexamethasone inhibits the reaction [[Toluene 2,4-Diisocyanate binds to ALB protein] which results in increased expression of CSF2 protein]" | 16908450 |
| D014051 | Toluene 2,4-Diisocyanate | "EGFR protein affects the reaction [[Toluene 2,4-Diisocyanate binds to ALB protein] which results in increased expression of CSF2 protein]" | 16908450 |
| D014051 | Toluene 2,4-Diisocyanate | "SB 203580 inhibits the reaction [[Toluene 2,4-Diisocyanate binds to ALB protein] which results in increased expression of CSF2 protein]" | 16908450 |
| D014051 | Toluene 2,4-Diisocyanate | "[Toluene 2,4-Diisocyanate binds to ALB protein] which results in increased expression of CSF2 protein" | 16908450 |
| D014051 | Toluene 2,4-Diisocyanate | "tyrphostin AG 1478 inhibits the reaction [[Toluene 2,4-Diisocyanate binds to ALB protein] which results in increased expression of CSF2 protein]" | 16908450 |
| D014118 | Toxins, Biological | "Toxins, Biological affects the expression of CSF2 mRNA" | 19682533 |
| D014212 | Tretinoin | CSF2 protein promotes the reaction [Tretinoin results in increased expression of CD83 protein] | 15454112 |
| D014222 | Triamcinolone Acetonide | Triamcinolone Acetonide inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein] | 10460758 |
| D014222 | Triamcinolone Acetonide | Triamcinolone Acetonide results in decreased secretion of CSF2 protein | 10868704 |
| C012589 | trichostatin A | [trichostatin A co-treated with Dexamethasone] inhibits the reaction [IL1B protein promotes the reaction [HIST4H4 protein modified form binds to CSF2 promoter]] | 12070353 |
| C012589 | trichostatin A | trichostatin A inhibits the reaction [Dexamethasone inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein]] | 12070353 |
| C012589 | trichostatin A | trichostatin A inhibits the reaction [[Theophylline co-treated with Dexamethasone] inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein]] | 12070353 |
| D014260 | Triclosan | Triclosan inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 mRNA] | 20507366 |
| C057693 | troglitazone | troglitazone results in increased expression of CSF2 mRNA | 19631733 |
| D014403 | Tubocurarine | Tubocurarine inhibits the reaction [Nicotine results in increased secretion of CSF2 protein] | 9606035 |
| D014414 | Tungsten | [Nickel co-treated with Cobalt co-treated with Tungsten] results in increased expression of CSF2 mRNA | 22198552 |
| D014414 | Tungsten | [Nickel co-treated with Iron co-treated with Tungsten] results in increased expression of CSF2 mRNA | 22198552 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [Particulate Matter results in increased secretion of CSF2 protein] | 19460412|2258134 |
| C101044 | tyrphostin AG 1478 | "tyrphostin AG 1478 inhibits the reaction [[Toluene 2,4-Diisocyanate binds to ALB protein] which results in increased expression of CSF2 protein]" | 16908450 |
| C113580 | U 0126 | U 0126 inhibits the reaction [kaempferol results in increased secretion of CSF2 protein] | 18346843 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Quercetin results in increased secretion of CSF2 protein] | 18346843 |
| D014520 | Urethane | Urethane results in increased expression of and results in increased secretion of CSF2 protein | 18082304 |
| D014520 | Urethane | Freund's Adjuvant inhibits the reaction [Urethane results in decreased expression of CSF2 mRNA] | 12810352 |
| D014520 | Urethane | IFNG protein inhibits the reaction [Urethane results in decreased expression of CSF2 mRNA] | 12810352 |
| D014520 | Urethane | [Urethane co-treated with Freund's Adjuvant] results in increased expression of CSF2 mRNA | 12400877 |
| C073339 | usnic acid | [usnic acid co-treated with Lipopolysaccharides] results in decreased expression of CSF2 mRNA | 22777745 |
| C073339 | usnic acid | usnic acid results in decreased expression of CSF2 mRNA | 21953288|2277774 |
| D014638 | Vanadates | Vanadates results in increased expression of CSF2 mRNA | 27427241 |
| C034028 | vanadyl sulfate | vanadyl sulfate results in increased expression of CSF2 protein | 18684396 |
| D001335 | Vehicle Emissions | "1,3-dimethylthiourea inhibits the reaction [Vehicle Emissions results in increased secretion of CSF2 protein]" | 10645887 |
| D001335 | Vehicle Emissions | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Vehicle Emissions results in increased secretion of CSF2 protein] | 10645887 |
| D001335 | Vehicle Emissions | Acetylcysteine inhibits the reaction [Vehicle Emissions analog results in increased secretion of CSF2 protein] | 10645887 |
| D001335 | Vehicle Emissions | Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased secretion of CSF2 protein] | 10645887 |
| D001335 | Vehicle Emissions | Cycloheximide inhibits the reaction [Vehicle Emissions results in increased secretion of CSF2 protein] | 10645887 |
| D001335 | Vehicle Emissions | Cytochalasin D inhibits the reaction [Vehicle Emissions results in increased secretion of CSF2 protein] | 10645887 |
| D001335 | Vehicle Emissions | Dactinomycin inhibits the reaction [Vehicle Emissions results in increased secretion of CSF2 protein] | 10645887 |
| D001335 | Vehicle Emissions | Genistein inhibits the reaction [Vehicle Emissions results in increased secretion of CSF2 protein] | 10645887 |
| D001335 | Vehicle Emissions | prolinedithiocarbamate inhibits the reaction [Vehicle Emissions results in increased secretion of CSF2 protein] | 10645887 |
| D001335 | Vehicle Emissions | SB 203580 inhibits the reaction [Vehicle Emissions results in increased secretion of CSF2 protein] | 10645887 |
| D001335 | Vehicle Emissions | sulforafan inhibits the reaction [Vehicle Emissions analog results in increased expression of CSF2 protein] | 16905640 |
| D001335 | Vehicle Emissions | Vehicle Emissions analog promotes the reaction [Histamine results in increased secretion of CSF2 protein] | 10051702 |
| D001335 | Vehicle Emissions | Vehicle Emissions analog results in increased expression of CSF2 protein | 16905640 |
| D001335 | Vehicle Emissions | Vehicle Emissions analog results in increased secretion of CSF2 protein | 10645887|1169445 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in decreased expression of CSF2 protein | 28189646 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in increased expression of CSF2 mRNA | 10645887 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in increased expression of CSF2 protein | 11306435 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in increased secretion of CSF2 protein | 10645887|1169445 |
| D001335 | Vehicle Emissions | CSF2 protein results in increased susceptibility to Vehicle Emissions | 10550748 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in decreased methylation of CSF2 gene | 25560391 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in increased expression of CSF2 mRNA | 10550748|1600764 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in increased expression of CSF2 mRNA | 24216475 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in increased expression of CSF2 | 19914270 |
| D014750 | Vincristine | Vincristine results in increased expression of CSF2 mRNA | 23649840 |
| C009687 | wortmannin | wortmannin inhibits the reaction [[IL3 protein co-treated with CSF2 protein co-treated with FLT3LG protein co-treated with KITLG protein] results in increased expression of LAT2 protein] | 23001822 |
| C009687 | wortmannin | wortmannin inhibits the reaction [[IL3 protein co-treated with CSF2 protein co-treated with FLT3LG protein co-treated with KITLG protein] results in increased phosphorylation of AKT1 protein] | 23001822 |
| C009687 | wortmannin | wortmannin inhibits the reaction [[IL3 protein co-treated with CSF2 protein co-treated with FLT3LG protein co-treated with KITLG protein] results in increased phosphorylation of RPS6 protein] | 23001822 |
| D015215 | Zidovudine | [IL3 protein co-treated with CSF2 protein] inhibits the reaction [Zidovudine results in decreased expression of CSF2RA mRNA] | 12084393 |
| D015215 | Zidovudine | [IL3 protein co-treated with CSF2 protein] inhibits the reaction [Zidovudine results in decreased expression of IL3RA mRNA] | 12084393 |
| D015032 | Zinc | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CSF2 mRNA | 16979875 |
| C016837 | zinc chloride | zinc chloride results in increased expression of CSF2 mRNA | 21540303|2742724 |
| C016837 | zinc chloride | NCF1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of CSF2 protein] | 18509044 |
| C016837 | zinc chloride | "N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [zinc chloride results in increased expression of CSF2 protein]" | 18509044 |
| C016837 | zinc chloride | PARP1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of CSF2 protein] | 18509044 |
| C016837 | zinc chloride | zinc chloride results in increased expression of CSF2 protein | 18509044 |
| C088658 | zoledronic acid | zoledronic acid results in increased expression of CSF2 mRNA | 24714768 |
| D015054 | Zymosan | CSF2 protein promotes the reaction [Zymosan results in increased secretion of CXCL8 protein] | 12176910 |
| D015054 | Zymosan | Zymosan results in increased expression of CSF2 protein | 12574323|1519191 |
| D015054 | Zymosan | [Zymosan co-treated with Lipopolysaccharides] results in increased expression of CSF2 protein | 16192389 |